Actively Recruiting
Registry of Vaccine Responses in Immune Compromised Patients
Led by Laure Pittet, MD-PhD · Updated on 2024-11-07
300
Participants Needed
1
Research Sites
235 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this project is to monitor, guide and document vaccination, vaccine responses, persistence of protection, vaccine efficacy and safety in immune compromised patients at various moment of their disease: right after the diagnosis, before the introduction of the immunosuppressive treatment, once the individual is under immunosuppressive treatment, or once immunosuppression is over.
CONDITIONS
Official Title
Registry of Vaccine Responses in Immune Compromised Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Immune compromised patient or patient who will soon be immunocompromised
- Informed consent as documented by signature
You will not qualify if you...
- Inability to follow study procedures due to language issues, psychological disorders, non-compliance, substance abuse, or similar
- Plan to move out of the country or have prolonged absence in the next 2 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospitals of Geneva
Geneva, Switzerland, 1211
Actively Recruiting
Research Team
L
Laure F Pittet, MD-PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here